Wordt geladen...
New agents for AML and MDS
The heterogeneity of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has led to a multiplicity of treatments, from cytotoxic agents to signal transduction modulators, cell cycle inhibitors, and epigenetic therapies. While some have shown promising initial results, the outlook for AM...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2793080/ https://ncbi.nlm.nih.gov/pubmed/19959100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2009.08.003 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|